Cargando…
A Case of Immune-Mediated Pneumonitis Associated With Dual Nivolumab and Ipilimumab Immunotherapy Treatment
Nivolumab and ipilimumab are immunotherapy agents used in combination to treat metastatic melanoma and have proven to be efficacious. However, they have been linked to the development of immune-mediated inflammatory processes in various organ systems and tissues, including immune-mediated pneumoniti...
Autores principales: | Al-Saghir, Tala, Suleiman, Noor, Goodman, Benjamin D, Ferguson, Michael W, Tejwani, Sheela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362781/ https://www.ncbi.nlm.nih.gov/pubmed/37485100 http://dx.doi.org/10.7759/cureus.40792 |
Ejemplares similares
-
Nivolumab-Induced Pneumonitis in a Patient With Urothelial Cancer
por: Kasi, Arbab Furquan Ud din, et al.
Publicado: (2023) -
Ipilimumab and Nivolumab-Induced Colitis in a Patient With Recurrent Metastatic Melanoma
por: Moein, Hamid-Reza, et al.
Publicado: (2021) -
Ipilimumab/nivolumab: Immune-related pneumonitis: 2 case reports
Publicado: (2020) -
Ipilimumab/nivolumab: Diffuse pneumonitis: case report
Publicado: (2020) -
Immunosuppressant Responsive Neuropsychiatric Systemic Lupus Erythematosus Manifestations Initially Diagnosed As Schizophrenia and Bipolar Disorder
por: Goodman, Benjamin D, et al.
Publicado: (2022)